Inotuzumab ozogamicin Intravenous and Insulin degludec
Determining the interaction of Inotuzumab ozogamicin Intravenous and Insulin degludec and the possibility of their joint administration.
No interaction was detected between the selected drugs or effects of joint drug administration are currently understudied, and it takes time and accumulated statistics to determine their interaction. A doctor should be consulted to address the issue of joint drug administration.
Generic Name: inotuzumab ozogamicin
Brand name: Besponsa
Synonyms: Inotuzumab ozogamicin, Inotuzumab Ozogamicin
Generic Name: insulin degludec
Brand name: Tresiba, Tresiba FlexTouch
Synonyms: Insulin Degludec
In the course of checking the drug compatibility and interactions, data from the following reference sources was used: Drugs.com, Rxlist.com, Webmd.com, Medscape.com.
- Inotuzumab ozogamicin Intravenous-Insulin Degludec (U-100) Prefilled Pens
- Inotuzumab ozogamicin Intravenous-Insulin Degludec (U-100) Vials
- Inotuzumab ozogamicin Intravenous-Insulin Degludec (U-200) Prefilled Pens
- Inotuzumab ozogamicin Intravenous-Insulin degludec and liraglutide
- Inotuzumab ozogamicin Intravenous-Insulin degludec and liraglutide Subcutaneous
- Inotuzumab ozogamicin Intravenous-Insulin degludec Subcutaneous
- Insulin degludec-Inova
- Insulin degludec-Inova 4/1 topical
- Insulin degludec-Inova 8/2 topical
- Insulin degludec-Inova ACT
- Insulin degludec-Inrebic
- Insulin degludec-Inspra